NCT01815931

Brief Summary

In this study, we aim to identify risk factors for hemolysis in blood samples drawn in the ED.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 21, 2013

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
Last Updated

November 11, 2013

Status Verified

November 1, 2013

Enrollment Period

4 months

First QC Date

March 19, 2013

Last Update Submit

November 8, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hemolysis rate

    1 day

Study Arms (1)

ED patients

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult (\> 16 y) patients admitted in the emergency departement during the study period

You may qualify if:

  • \> 16 years

You may not qualify if:

  • In vivo hemolysis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital, Geneva

Geneva, Canton of Geneva, 1211, Switzerland

Location

MeSH Terms

Conditions

HemolysisEmergencies

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsDisease Attributes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, MPH

Study Record Dates

First Submitted

March 19, 2013

First Posted

March 21, 2013

Study Start

June 1, 2013

Primary Completion

October 1, 2013

Study Completion

October 1, 2013

Last Updated

November 11, 2013

Record last verified: 2013-11

Locations